GlassScriptPhysician profile
Ruwan P Ratnayake
NPI 1619397338
$17,768.59
in general payments reported to CMS, 2019-2025
27 companies · $3,350 in 2025
The $3,350 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,157 · 2021: $4,081 · 2022: $3,078 · 2023: $1,324 · 2024: $3,779 · 2025: $3,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,435 · Travel and Lodging: $2,986 · Education: $31.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,434.73 |
| Travel and Lodging | $2,985.75 |
| Education | $31.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,768.82 | 2023-2025 | Xlif, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Nuvasive, INC. | $4,210.85 | 2020-2023 | Acp, Xlif, Alif |
| Seaspine Orthopedics Corporation | $1,509.92 | 2020 | |
| Evolution Surgical, INC | $1,400.23 | 2025 | |
| Alphatec Spine, INC | $1,349.43 | 2021 | |
| Relievant Medsystems, INC. | $1,154.38 | 2022-2023 | Intracept |
| Viseon, INC. | $700.00 | 2021 | |
| Medtronic, INC. | $604.61 | 2021-2025 | Unid_pass, Endoskeleton Tl Nanolock Surface Technology, Catalyft Pl Expandable Interbody System |
| Medtronic USA, INC. | $510.38 | 2020 | |
| Si-Bone, INC. | $410.36 | 2020-2024 | |
| Arthrex, INC. | $268.20 | 2025 | |
| Kuros Biosciences USA, INC | $197.37 | 2024 | Magnetos |
| Augmedics INC. | $130.89 | 2024 | Xvision |
| Depuy Synthes Sales INC. | $108.09 | 2021 | |
| Cerapedics INC. | $101.87 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $63.61 | 2023 | Evoke Scs |
| Abbott Laboratories | $46.89 | 2021 | |
| Ethicon US, LLC | $34.42 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $33.97 | 2024 | Dysport |
| Collegium Pharmaceutical, INC. | $32.90 | 2023-2024 | Belbuca |
| Scilex Pharmaceuticals INC. | $27.91 | 2021 | |
| Amgen INC. | $21.02 | 2023 | Evenity, Prolia |
| Spr Therapeutics, INC | $19.91 | 2024 | Sprint Pns System |
| Pfizer INC. | $17.69 | 2021 | |
| Nalu Medical, INC. | $16.26 | 2024 | Nalu Neurostimulation System |
| Stryker Corporation | $15.00 | 2021 | |
| Boston Scientific Corporation | $13.61 | 2024 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruwan Ratnayake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.